Brokerages Set GSK plc (LON:GSK) Target Price at GBX 1,805.83

Shares of GSK plc (LON:GSK) have been given an average rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is GBX 1,805.83 ($21.97).

Several research analysts have recently commented on GSK shares. Berenberg Bank lowered their price target on GSK from GBX 1,820 ($22.14) to GBX 1,600 ($19.47) and set a “buy” rating for the company in a research report on Friday, November 29th. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a research report on Tuesday, January 7th.

Insider Buying and Selling

In other GSK news, insider Jonathan Symonds bought 7,150 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were acquired at an average price of GBX 1,394 ($16.96) per share, with a total value of £99,671 ($121,269.01). Insiders bought 8,658 shares of company stock worth $11,950,792 over the last 90 days. 1.61% of the stock is owned by insiders.

GSK Stock Performance

LON:GSK opened at GBX 1,363.26 ($16.59) on Tuesday. GSK has a fifty-two week low of GBX 1,282.50 ($15.60) and a fifty-two week high of GBX 1,823.50 ($22.19). The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. The company has a 50 day moving average price of GBX 1,343.53 and a 200 day moving average price of GBX 1,468.96. The stock has a market capitalization of £55.62 billion, a P/E ratio of 1,206.42, a PEG ratio of 1.24 and a beta of 0.31.

GSK Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, January 9th. Investors of record on Thursday, November 14th were paid a dividend of GBX 15 ($0.18) per share. The ex-dividend date of this dividend was Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s payout ratio is 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.